To evaluate the expression difference of PLEK2 in tumors and normal tissues, the transcription levels of PLEK2 in pan‐cancers were initially analyzed using the TIMER2, CCLE, and Oncomine databases (Figure 1). This evidence concerns the gene PLEK2 and cancer.